Addex Therapeutics Ltd Finance Income Cost
Addex Therapeutics Ltd (ADXN) reported Finance Income Cost of CHF 5.83 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceIncomeCost · last filed 2025-09-30
- Addex Therapeutics Ltd finance income cost for the quarter ending 2025-06-30 was 5.83K CHF.
- Addex Therapeutics Ltd finance income cost for the quarter ending 2024-06-30 was -26.70K CHF.
- Addex Therapeutics Ltd finance income cost for the quarter ending 2023-06-30 was -128.38K CHF.
- Addex Therapeutics Ltd finance income cost for the quarter ending 2022-06-30 was -129.04K CHF.
| Period end | Finance Income Cost 3 month | Finance Income Cost 6 month | Finance Income Cost 12 month | Finance Income Cost 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | 5.83K CHF 6-K · filed 2025-09-30 | -13.32K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 23.05K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | -26.70K CHF 6-K · filed 2025-09-30 | 26.22K CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | -257.19K CHF 20-F · filed 2025-05-15 | -274.93K CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | -128.38K CHF 6-K/A · filed 2023-12-21 | -136.04K CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | -263.06K CHF 20-F · filed 2025-05-15 | -284.01K CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | -129.04K CHF 6-K/A · filed 2023-12-21 | -190.19K CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 154.00K CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | -183.51K CHF 6-K/A · filed 2022-09-14 | 324.90K CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | -615.33K CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | -176.45K CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | -220.17K CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | -45.35K CHF 20-F · filed 2020-04-27 |